| Ahmad Osama Rez, MD | |
|
1 Saint Anthonys Way, Alton, IL 62002-4568 | |
| (314) 317-0600 | |
| (314) 317-0606 |
| Full Name | Ahmad Osama Rez |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 1 Saint Anthonys Way, Alton, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356537179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036.131216 (Illinois) | Secondary |
| 208M00000X | Hospitalist | 2010014085 (Missouri) | Secondary |
| 208M00000X | Hospitalist | 036.131216 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm St Clare Health Center | Fenton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galen Inpatient Physicians Pc | 3678464633 | 345 |
| Galen Inpatient Physicians Pc | 3678464633 | 345 |
News Archive
France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.
Achillion Pharmaceuticals, Inc. today reported additional preliminary data from its Phase 1b clinical trial of ACH-1625, which demonstrated that both the third and fourth patient cohorts receiving treatment with ACH-1625 achieved meaningful reductions in HCV RNA after five-day monotherapy, with continued safety and tolerability in patients with hepatitis C.
A 25-year-old federal drug discount program has grown so big and controversial that it faces a fight for survival as federal officials and lawmakers furiously debate the program's reach.
In August, the Ontario Superior Court of Justice dismissed a malpractice lawsuit filed against two physicians who refused to provide cardiopulmonary resuscitation to an 88-year-old man with multiple comorbidities and multiorgan failure.
› Verified 8 days ago
| Entity Name | Galen Inpatient Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538714688 PECOS PAC ID: 3678464633 Enrollment ID: O20191115000362 |
News Archive
France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.
Achillion Pharmaceuticals, Inc. today reported additional preliminary data from its Phase 1b clinical trial of ACH-1625, which demonstrated that both the third and fourth patient cohorts receiving treatment with ACH-1625 achieved meaningful reductions in HCV RNA after five-day monotherapy, with continued safety and tolerability in patients with hepatitis C.
A 25-year-old federal drug discount program has grown so big and controversial that it faces a fight for survival as federal officials and lawmakers furiously debate the program's reach.
In August, the Ontario Superior Court of Justice dismissed a malpractice lawsuit filed against two physicians who refused to provide cardiopulmonary resuscitation to an 88-year-old man with multiple comorbidities and multiorgan failure.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ahmad Osama Rez, MD 12101 Woodcrest Executive Dr, Suite 210, Saint Louis, MO 63141-5047 Ph: (314) 317-0600 | Ahmad Osama Rez, MD 1 Saint Anthonys Way, Alton, IL 62002-4568 Ph: (314) 317-0600 |
News Archive
France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.
Achillion Pharmaceuticals, Inc. today reported additional preliminary data from its Phase 1b clinical trial of ACH-1625, which demonstrated that both the third and fourth patient cohorts receiving treatment with ACH-1625 achieved meaningful reductions in HCV RNA after five-day monotherapy, with continued safety and tolerability in patients with hepatitis C.
A 25-year-old federal drug discount program has grown so big and controversial that it faces a fight for survival as federal officials and lawmakers furiously debate the program's reach.
In August, the Ontario Superior Court of Justice dismissed a malpractice lawsuit filed against two physicians who refused to provide cardiopulmonary resuscitation to an 88-year-old man with multiple comorbidities and multiorgan failure.
› Verified 8 days ago
Fardina Malik, M. D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 Fax: 618-463-7216 | |
Eric Michael Guenther, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 Fax: 618-463-7216 | |
Dr. Mena Metias, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 | |
Dr. John Albert Richards Jr., M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 Fax: 618-463-7216 |